Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Thomasseau

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Brain Research|December 8, 2019
Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic miceBaptiste Porte, Gwendolyn Marguerit, Sylvie Thomasseau, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2018
Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic MiceSarah Gourmaud, Priscilla Thomas, Sylvie Thomasseau, et al.
Developmental Biology|August 18, 2006
Involvement of Pleiotrophin in CNTF-mediated differentiation of the late retinal progenitor cellsJérôme Roger, Valérie Brajeul, Sylvie Thomasseau, et al.
Plos One|February 14, 2025
The bone phenotype associated with cherubism is independent of Caspase-1-dependent inflammasome activation in the mouseBadre-Victor Rabhi, Sylvie Thomasseau, Xavier Decrouy, et al.
The Journal of Biological Chemistry|December 17, 2016
Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of RanvierPierre-Marie Martin, Carmen Cifuentes-Diaz, Jérôme Devaux, et al.
Orphanet Journal of Rare Diseases|June 12, 2026
Exploring a cherubism bone phenotype outside the craniofacial regionAnne Morice, Philippe Drabent, Sylvie Thomasseau, et al.
Plos One|May 26, 2018
PKR modulates abnormal brain signaling in experimental obesityMariko Taga, François Mouton-Liger, Malha Sadoune, et al.
Aging Cell|March 2, 2019
PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesionsMarion Tible, François Mouton Liger, Julien Schmitt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Brain Research|December 8, 2019
Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic miceBaptiste Porte, Gwendolyn Marguerit, Sylvie Thomasseau, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2018
Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic MiceSarah Gourmaud, Priscilla Thomas, Sylvie Thomasseau, et al.
Developmental Biology|August 18, 2006
Involvement of Pleiotrophin in CNTF-mediated differentiation of the late retinal progenitor cellsJérôme Roger, Valérie Brajeul, Sylvie Thomasseau, et al.
Plos One|February 14, 2025
The bone phenotype associated with cherubism is independent of Caspase-1-dependent inflammasome activation in the mouseBadre-Victor Rabhi, Sylvie Thomasseau, Xavier Decrouy, et al.
The Journal of Biological Chemistry|December 17, 2016
Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of RanvierPierre-Marie Martin, Carmen Cifuentes-Diaz, Jérôme Devaux, et al.
Orphanet Journal of Rare Diseases|June 12, 2026
Exploring a cherubism bone phenotype outside the craniofacial regionAnne Morice, Philippe Drabent, Sylvie Thomasseau, et al.
Plos One|May 26, 2018
PKR modulates abnormal brain signaling in experimental obesityMariko Taga, François Mouton-Liger, Malha Sadoune, et al.
Aging Cell|March 2, 2019
PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesionsMarion Tible, François Mouton Liger, Julien Schmitt, et al.
Pageof 1